North America - United States • Healthcare
Skadden, Arps, Slate, Meagher & Flom LLP
Under the leadership of Washington DC’s Paul Schnell, Skadden, Arps, Slate, Meagher & Flom LLP offers a range of services to life sciences companies, including assisting target companies in their acquisitions by major life sciences players, cross-border licensing agreements, and disputes tied to a variety of sector-specific and broader commercial issues. Boston-based Graham Robinson advises both public and private companies on transactions in the sector, often representing target companies.
Legal 500 Editorial commentary
Key clients
- Agenus
- Alcon
- Alnylam Pharmaceuticals
- Array BioPharma
- BELLUS Health Inc.
- Biogen
- Centene Corporation
- CTI BioPharma
- Endo International plc
- Exact Sciences Corporation
- Exelixis
- Genomic Health
- Intercept Pharmaceuticals
- IVERIC bio
- Mirati Therapeutics
- NeoGenomics
- POINT Biopharma Global
- Purdue Pharma
- Theravance Biopharma
- Vertex Pharmaceuticals
- vTv Therapeutics
Work highlights
- Represented Agenus Inc. in resolving an action brought against Recepta Biopharma S.A. in the U.S. District Court for the District of Massachusetts stemming from a dispute arising under a collaboration agreement.
- Represented Alnylam Pharmaceuticals, Inc. in its $2.8bn partnership with Roche to develop and commercialize Alnylam’s investigational RNA interference therapeutic zilebesiran for hypertension.
- Represented Purdue Pharma L.P. in connection with its resolution of US Department of Justice civil and criminal investigations concerning the sale and marketing of opioid products.
Practice head
The lawyer(s) leading their teams.
Paul Schnell